Molecular Testing for Thyroid Follicular Lesions of Uncertain Significance (FLUS)? (AMW) Session
2021 AAO-HNSF Annual Meeting & OTO Experience
This presentation will present a very practical when and how to apply molecular marker testing in select thyroid nodules, AUS/FLUS (Bethesda 3) and Follicular Neoplasm (Bethesda 4). Available testing on the market will be reviewed without any commercial bias.
Description
Learning Objective: 1. To describe the critical anatomy necessary to know for minimally invasive pituitary surgery. 2. To provide tips and tricks in order to optimize outcomes in minimally invasive pituitary surgery. 3. To review team-building, advantages, and expected outcomes of endoscopic pituitary surgery. Faculty: Brendan Stack, MD, FACE(Consulting Fee: Medtronic).